Skip to main content
TipRanks
Go Ultimate75% OFF

US Stem Cell (USRM) Financial Statements

31 Followers

US Stem Cell Financial Overview

US Stem Cell's market cap is currently $642. The company's EPS TTM is $-0.00; its P/E ratio is -0.02; US Stem Cell has not announced its next earnings date. See an overview of income statement, balance sheet, and cash flow financials.

Financial overview
Dec 22Dec 21Dec 20Dec 19Dec 18
Income Statement
Total Revenue$ 82.05K$ 200.75K$ 277.09K$ 3.07M$ 6.70M
Gross Profit$ 58.28K$ 148.72K$ 212.97K$ 1.74M$ 4.59M
Operating Income$ -1.72M$ -2.14M$ -2.40M$ -3.42M$ -1.10M
EBITDA$ -2.17M$ -151.41K$ -2.16M$ -2.61M$ -508.49K
Net Income$ -2.86M$ -3.29M$ -2.89M$ -3.84M$ -2.16M
Balance Sheet
Cash & Short-Term Investments$ 5.13K$ 39.39K$ 18.57K$ -10.00K$ 1.36M
Total Assets$ 68.04K$ 51.00K$ 88.15K$ 89.84K$ 1.82M
Total Debt$ 8.95M$ 8.02M$ 7.48M$ 6.18M$ 5.05M
Net Debt$ 8.94M$ 7.98M$ 7.47M$ 6.18M$ 3.69M
Total Liabilities$ 14.81M$ 12.82M$ 11.67M$ 9.57M$ 8.70M
Stockholders' Equity$ -14.75M$ -12.77M$ -11.58M$ -9.48M$ -6.88M
Cash Flow
Free Cash Flow$ -304.85K$ -1.06M$ -478.89K$ -1.21M$ 602.47K
Operating Cash Flow$ -304.85K$ -1.06M$ -478.89K$ -1.21M$ 602.47K
Investing Cash Flow$ 0.00$ 0.00$ 0.00$ 166.83K$ 311.70K
Financing Cash Flow$ 270.59K$ 1.08M$ 497.46K$ -312.99K$ -543.82K

Currency in USD

US Stem Cell Earnings and Revenue History

-5M05M10M-4500 %-3000 %-1500 %0 %EarningsProfit Margin201720182019202020212022RevenueEarningsProfit Margin

US Stem Cell Liabilities to Assets

06M12M18M0 %10000 %20000 %30000 %LiabilitiesLiabilities to Assets201720182019202020212022AssetsLiabilitiesLiabilities to Assets

US Stem Cell Cash Flow

-1.5M-1M-500K0500K1M1.5M201720182019202020212022OperatingInvestingFinancing

US Stem Cell Forecast EPS vs Actual EPS

0000000Q2 18Q3 18Q4 18Q1 19Q2 19EPS EstimateBeatMiss